Clinical Trial Update: Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding radiotherapy to leuprorelin improves outcomes in locally advanced prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Leuprorelin (leuprorelin)

Snippet

Sponsor: Takeda | Conditions: Prostatic Neoplasms, Locally Advanced | Phase 3 | Status: COMPLETED